NeuroOne Medical Technologies Corporation
Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 05 Nov 2025 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Past financial statements no longer reliable (8-K Item 4.02)
The company stated in a Form 8-K (Item 4.02) filed on 22 May 2026 that previously issued financial statements should no longer be relied upon. This usually leads to a restatement of past results.
More details →NeuroOne Medical Technologies Corporation — Overview & Financial Snapshot
NeuroOne Medical Technologies Corporation (NasdaqCM: NMTC) is a Healthcare company, ranked #3,416 of 6,774 companies globally and #1,454 of 4,000 in United States on PositoAI, with a Positivity Score of 20,585. Its market capitalisation is ₹84.23 Cr ($8.92M), P/E ratio is -1.0 and P/B ratio is 2.37. It currently has 1 active red flag (PosiRed) and 1 yellow flag (PosiYellow, 6/10 points) on record.
For financial statements, ratio trends and score history, Go Deep →